Adaptive Biotechnologies Corporation ADPT
25.81 USD +0.75 (+2.99%)
Nov 3, 2026, 3:57 PM EST
25.33 Day range 26.46
12.00 52-week range 30.74
- YTD
- +58.93%
- 1 year
- +48.85%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 30.21 +17.1% upside
Now 25.81
- Target (low)
- 21.00
- Target (mean)
- 30.21
- Target (high)
- 35.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 9
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09552 | -0.11 – -0.08 | 0.06 | -259.2% | 71.60M | -23.8% | 7 |
| Next quarter | -0.06409 | -0.08 – -0.04 | -0.09 | +28.8% | 79.29M | +10.6% | 7 |
| Current year | -0.54243 | -0.57 – -0.51 | -0.39 | -39.1% | 293.25M | +5.9% | 7 |
| Next year | -0.18029 | -0.32 – -0.01 | -0.54243 | +66.8% | 360.14M | +22.8% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 13, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 29, 2026 | Goldman Sachs | Initiated | — | Buy |
| Sep 22, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 17, 2026 | BTIG | Reiterated | Buy | Buy |
| May 12, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 6, 2026 | Guggenheim | Reiterated | Buy | Buy |
| May 6, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 6, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 11, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 22, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 15, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 13, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 30, 2025 | Guggenheim | Initiated | — | Buy |
| Aug 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 6, 2025 | TD Cowen | Maintained | Buy | Buy |